Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Gordon

Showing results (111-120 of 200) with videos related to

Pageof 20
Sort By:
Journal of Clinical Medicine|March 28, 2026
The Limited Evidence Base for Multilevel Lumbar Interbody Fusion and Its Consequences for Clinical Conclusions: A Systematic ReviewEvan R Simpson, Casey Slattery, Kalyn Smith, et al.
Frontiers in Neurology|December 5, 2015
Brain Network Activation as a Novel Biomarker for the Return-to-Play Pathway Following Sport-Related Brain InjuryAdam W Kiefer, Kim Barber Foss, Amit Reches, et al.
Clinical Ophthalmology (Auckland, N.Z.)|March 23, 2026
Myopic and Astigmatic Laser in situ Keratomileusis Using a Ray Tracing-Based Treatment Algorithm with a Personalized Ablation ProfileRonald R Krueger, Vance Thompson, Kerry Solomon, et al.
Journal of Substance Abuse Treatment|June 4, 2017
Healthcare utilization in adults with opioid dependence receiving extended release naltrexone compared to treatment as usualWilliam E Soares, Donna Wilson, Niels Rathlev, et al.
Canadian Journal of Veterinary Research = Revue Canadienne De Recherche Veterinaire|April 6, 2023
Effect of dietary iron supplementation on the equine fecal microbiomeJulia Assis Arantes, Alexandre Secorun Borges, Luiza Stachewski Zakia, et al.
Cancer|October 6, 2010
Phase 1 dose-escalation trial of tremelimumab plus sunitinib in patients with metastatic renal cell carcinomaBrian I Rini, Mark Stein, Pat Shannon, et al.
American Journal of Clinical Oncology|April 9, 2008
Gemcitabine plus celecoxib in patients with advanced or metastatic pancreatic adenocarcinoma: results of a phase II trialTomislav Dragovich, Howard Burris, Patrick Loehrer, et al.
Journal of Vascular and Interventional Radiology : JVIR|July 12, 2011
Endovascular treatment of visceral and renal artery aneurysmsVahid Etezadi, Ripal T Gandhi, James F Benenati, et al.
Cancer Chemotherapy and Pharmacology|March 28, 2019
First-in-human study to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of the anti-CD27L antibody-drug conjugate AMG 172 in patients with relapsed/refractory renal cell carcinomaChristophe Massard, Jean-Charles Soria, Jürgen Krauss, et al.
Journal of Rehabilitation Medicine|November 17, 2005
Erectile dysfunction in spinal cord injury: a cost-utility analysisNicole Mittmann, B Catherine Craven, Michael Gordon, et al.
Pageof 20

Showing results (111-120 of 200) with videos related to

Sort By:
Pageof 20
Journal of Clinical Medicine|March 28, 2026
The Limited Evidence Base for Multilevel Lumbar Interbody Fusion and Its Consequences for Clinical Conclusions: A Systematic ReviewEvan R Simpson, Casey Slattery, Kalyn Smith, et al.
Frontiers in Neurology|December 5, 2015
Brain Network Activation as a Novel Biomarker for the Return-to-Play Pathway Following Sport-Related Brain InjuryAdam W Kiefer, Kim Barber Foss, Amit Reches, et al.
Clinical Ophthalmology (Auckland, N.Z.)|March 23, 2026
Myopic and Astigmatic Laser in situ Keratomileusis Using a Ray Tracing-Based Treatment Algorithm with a Personalized Ablation ProfileRonald R Krueger, Vance Thompson, Kerry Solomon, et al.
Journal of Substance Abuse Treatment|June 4, 2017
Healthcare utilization in adults with opioid dependence receiving extended release naltrexone compared to treatment as usualWilliam E Soares, Donna Wilson, Niels Rathlev, et al.
Canadian Journal of Veterinary Research = Revue Canadienne De Recherche Veterinaire|April 6, 2023
Effect of dietary iron supplementation on the equine fecal microbiomeJulia Assis Arantes, Alexandre Secorun Borges, Luiza Stachewski Zakia, et al.
Cancer|October 6, 2010
Phase 1 dose-escalation trial of tremelimumab plus sunitinib in patients with metastatic renal cell carcinomaBrian I Rini, Mark Stein, Pat Shannon, et al.
American Journal of Clinical Oncology|April 9, 2008
Gemcitabine plus celecoxib in patients with advanced or metastatic pancreatic adenocarcinoma: results of a phase II trialTomislav Dragovich, Howard Burris, Patrick Loehrer, et al.
Journal of Vascular and Interventional Radiology : JVIR|July 12, 2011
Endovascular treatment of visceral and renal artery aneurysmsVahid Etezadi, Ripal T Gandhi, James F Benenati, et al.
Cancer Chemotherapy and Pharmacology|March 28, 2019
First-in-human study to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of the anti-CD27L antibody-drug conjugate AMG 172 in patients with relapsed/refractory renal cell carcinomaChristophe Massard, Jean-Charles Soria, Jürgen Krauss, et al.
Journal of Rehabilitation Medicine|November 17, 2005
Erectile dysfunction in spinal cord injury: a cost-utility analysisNicole Mittmann, B Catherine Craven, Michael Gordon, et al.
Pageof 20